Unbound MEDLINE

Intravenous injection of metallic mercury: case report and course of mercury during chelation therapy with DMPS. Clinical toxicology (Philadelphia, Pa.) [Clin Toxicol (Phila)] Journal article

 
TitleIntravenous injection of metallic mercury: case report and course of mercury during chelation therapy with DMPS.
Author(s)Vallant B, Deutsch J, Muntean M, Goessler W 
InstitutionKarl-Franzens University Graz, Institute of Chemistry-Analytical Chemistry, Graz, Austria.
SourceClin Toxicol (Phila) 2008 Jul; 46(6):566-9.
AbstractIntroduction. Although several cases of IV injection of metallic mercury have been reported, it still remains an uncommon event. Case report. A 34-year-old male came to hospital because complaining of pleuritic chest pain. X-ray showed radio dense punctate lesions in both lung fields, as well as around both elbows. Mercury concentration in blood (140 mug/L) and urine (320 mug/L) from the patient were significantly elevated, compared with the reference concentrations of </= 2.0 mug/L mercury in blood and urine. The course of renal elimination of mercury and the mercury concentration in whole blood during 5 months of chelation therapy with sodium 2,3-dimercapto-1-propanesulfonate (Dimaval(R)) were monitored. Furthermore, the time-course of mercury in scalp hair from the patient was determined.
Conclusion. We report a case of probable consecutive IV administration of metallic mercury.
Languageeng
Pub Type(s)Journal Article
PubMed ID18584372
  
Advertise on this site.